MedTrace Logo

Psychosocial Group Interventions for Depression

NCT02149381 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2017-11-24

No results posted yet for this study

Summary

A total of 384 patients suffering from chronic depressive disorder will be randomized to receive treatment as usual, CBASP, or befriending for a period of five months. The primary outcome is change in Montgomery-Åsberg Depression Scale. Secondary outcomes include changes in self-reported psychiatric symptoms, biomarkers determined from venous blood samples, and neurophysiological parameters. The data gathering is performed at pre- and post intervention stages (i.e., at baseline and at five months). A follow-up questionnaire is sent to the participants six months after the intervention.

Conditions

Interventions

BEHAVIORAL

CBASP

Cognitive behavioral group intervention for individuals suffering from chronic depression

BEHAVIORAL

Befriending

Social support intervention, sessions once per week

OTHER

Treatment as usual

Conventional psychiatric outpatient treatment (individual counseling)

Sponsors & Collaborators

  • Jyväskylä Central Hospital

    collaborator OTHER

  • University of Eastern Finland

    lead OTHER

Principal Investigators

  • Soili Lehto, Professor · University of Eastern Finland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02149381 on ClinicalTrials.gov